Shopping Cart
Remove All
Your shopping cart is currently empty
Telazorlimab (GBR-830) is a humanized monoclonal antibody targeting the OX40 co-stimulatory receptor on activated T cells, and is used to treat lupus erythematosus and atopic dermatitis.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $247 | - | In Stock | |
| 5 mg | $563 | - | In Stock | |
| 10 mg | $897 | - | In Stock | |
| 25 mg | $1,330 | - | In Stock | |
| 50 mg | $1,790 | - | In Stock | |
| 100 mg | $2,420 | - | In Stock |
| Description | Telazorlimab (GBR-830) is a humanized monoclonal antibody targeting the OX40 co-stimulatory receptor on activated T cells, and is used to treat lupus erythematosus and atopic dermatitis. |
| In vitro | In T cell-mediated diseases, including atopic dermatitis (AD), Telazorlimab plays an important role[1]. |
| Synonyms | ISB-830, GBR-830 |
| Molecular Weight | 145.24 kDa |
| Cas No. | 2126777-87-3 |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.